AI assistant
REPLIGEN CORP — Director's Dealing 2022
Mar 3, 2022
30826_dirs_2022-03-02_a66ca9e4-c5c0-4e5d-a170-aa0b188dd3ac.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2022-02-27
Reporting Person: Snodgres Jon (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-27 | Common Stock | F | 695 | $196.70 | Disposed | 32940 | Direct |
| 2022-02-28 | Common Stock | F | 661 | $196.70 | Disposed | 32279 | Direct |
| 2022-02-28 | Common Stock | A | 5922 | $0.00 | Acquired | 38201 | Direct |
| 2022-02-28 | Common Stock | F | 2468 | $196.70 | Disposed | 35733 | Direct |
Footnotes
F1: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.
F2: Represents shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on February 28, 2019. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award.
F3: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the settlement of the PSUs.